We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
-8.14%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.56B
AUM Growth
-$1.36B
(-28%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-31.07%
Top 10 Holdings %
Top 10 Hldgs %
29.11%
Holding
1,521
New
512
Increased
155
Reduced
168
Closed
620
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$27.4M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$13.6M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$13.4M |
| 4 |
Digital Realty Trust
DLR
|
+$12.3M |
| 5 |
Netflix
NFLX
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$193M |
| 2 |
Amazon
AMZN
|
+$126M |
| 3 |
Advanced Micro Devices
AMD
|
+$77.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$49.2M |
| 5 |
XYZ
Block Inc
XYZ
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.48% |
| 2 | Consumer Discretionary | 1.2% |
| 3 | Communication Services | 1.16% |
| 4 | Technology | 1.08% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CALL
Dillards
DDS
$9.2B
| $2.28M | 0.06% |
+8,500
| New | +$2.19M |
|
277
PUT
Ascendis Pharma A/S
ASND
$16.5B
| $2.28M | 0.06% |
+19,400
| New | +$2.25M |
|
|
MGI
278
DELISTED
MoneyGram International, Inc. New
MGI
| $2.27M | 0.06% |
+215,000
| New | +$2.07M |
|
|
SGFY
279
CALL
DELISTED
Signify Health, Inc.
SGFY
| $2.27M | 0.06% |
124,900
+102,800
| +465% | +$1.47M |
|
280
CALL
DaVita
DVA
$15.5B
| $2.26M | 0.06% |
20,000
| – | – |
|
|
VRAY
281
DELISTED
ViewRay, Inc.
VRAY
| $2.26M | 0.06% |
576,226
+484,622
| +529% | +$2.06M |
|
282
United Therapeutics
UTHR
$26.1B
| $2.24M | 0.06% |
+12,500
| New | +$2.38M |
|
|
CUTR
283
DELISTED
Cutera, Inc.
CUTR
| $2.24M | 0.06% |
+32,500
| New | +$1.31M |
|
284
PUT
Americold
COLD
$4.21B
| $2.23M | 0.06% |
+80,000
| New | +$2.25M |
|
|
ISEE
285
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.23M | 0.06% |
132,500
+122,500
| +1,225% | +$1.81M |
|
286
CALL
Wayfair
W
$11.8B
| $2.22M | 0.06% |
20,000
-9,500
| -32% | -$1.34M |
|
287
CALL
GSK
GSK
$107B
| $2.19M | 0.06% |
+40,320
| New | +$2.19M |
|
|
EBIX
288
DELISTED
Ebix Inc
EBIX
| $2.17M | 0.06% |
+65,500
| New | +$2.05M |
|
289
PUT
Ginkgo Bioworks
DNA
$498M
| $2.14M | 0.06% |
+13,250
| New | +$2.58M |
|
290
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
| $2.13M | 0.06% |
171,800
-11,000
| -6% | -$170K |
|
|
LSXMA
291
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.08M | 0.06% |
+62,022
| New | +$2.18M |
|
292
PUT
Envista
NVST
$4.62B
| $2.06M | 0.06% |
+42,400
| New | +$1.96M |
|
|
FLOW
293
CALL
DELISTED
SPX FLOW, Inc.
FLOW
| $2.06M | 0.06% |
23,900
| – | – |
|
294
CALL
BP
BP
$112B
| $2.06M | 0.06% |
+70,000
| New | +$2.13M |
|
295
PUT
Johnson Controls International
JCI
$85.1B
| $2.05M | 0.06% |
31,200
-26,800
| -46% | -$1.84M |
|
296
Equinix
EQIX
$99.4B
| $2.04M | 0.06% |
2,750
+2,250
| +450% | +$1.62M |
|
297
CALL
Trupanion
TRUP
$1.13B
| $2M | 0.06% |
+22,500
| New | +$2.07M |
|
298
PUT
Levi Strauss
LEVI
$9.49B
| $1.98M | 0.06% |
+100,000
| New | +$2.16M |
|
299
CALL
Herbalife
HLF
$1.3B
| $1.97M | 0.06% |
+65,000
| New | +$2.54M |
|
|
NBIS
300
CALL
Nebius Group N.V.
NBIS
$37.6B
| $1.97M | 0.06% |
103,800
-235,000
| -69% | -$11.2M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2022 Portfolio in Review
As of Q1 2022, SG3 Management held 1,521 positions worth $3.56B, down 28% from $4.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
SG3 Management withdrew a net $1.11B in Q1 2022, closing 620 positions and reducing 168 holdings. Its most notable exit was Tesla, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, SG3 Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $13.5M.
- SG3 Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 30,000 shares worth $13.5M.
- SG3 Management added most to Bausch Health in Q1 2022, an estimated $27.4M increase.
- SG3 Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $126M.
- SG3 Management fully exited Tesla in Q1 2022, selling an estimated $193M.
- SG3 Management's ten largest holdings make up 29% of its $3.56B portfolio in Q1 2022.
- SG3 Management opened 512 new positions and closed 620 in Q1 2022.
- SG3 Management's portfolio value fell 28% quarter-over-quarter to $3.56B.
Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.